Program

CIMT Endeavour 2016
“Translating cancer science into products and companies”
May 11, 2016 | from 08:00 - 12:00
Rheingoldhalle Congress Center Mainz
Rheinstr. 66; 55116 Mainz/Germany

Endeavour is a CIMT activity focusing on the translation and commercialization of cancer immunotherapies and diagnostics.

The 2016 workshop will take place as part of the CIMT Annual Meeting and will provide an opportunity for scientists to learn about the business potential of their research. Experts in cancer immunotherapy, intellectual property and commercialization will discuss the strenghts and weaknesses of business ideas in the field of cancer immunotherapies and diagnostics. In the second part of the workshop, scientists from biotech companies engaged in cancer immunotherapy development will talk about their company’s scientific background and how the company turned a business idea into a successful enterprise. To give participants a broad impression of the intellectual property and commercialization potential in the field, the workshop will also focus on the corporate view and will outline the influence and opportunities offered by the international markets.

 

Speakers

Speakers 2016

 

Stefan Ries
Global Head External Innovation Discover Oncology, Roche pRED

Lothar Germeroth
SVP and Managing Director, Juno Therapeutics, Inc.

Georg Schnappauf
Zwicker Schnappauf & Partner

David Philipps
Partner, SR One Ltd.

Derek Jantz
Chairman and CSO, Precision BioSciences, Inc.

Program Committee

CIMT:

Cedrik Britten
Björn-Philipp Kloke

Ci3:

Rainer Wessel
Andrea Schilz

Oslo Cancer Cluster:

Jutta Heix